Report: Government oversight threatens California's biotech boom

01/23/2008 | Forbes

Biotech businesses in California -- including those focused on drug development, medical devices and diagnostics -- brought in more than 40% of the $7.4 billion in biotech venture capital in 2006, according to a new PriceWaterhouseCoopers report. The industry's steady growth could be hampered, however, as the federal government is likely to have increased involvement in oversight of drug safety and cost-effectiveness.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA